EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Sofia Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Chris D Buckley, Frank Buttgereit, Vivian Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan Gomez-Reino, Laure Gossec, Jacques-Eric Gottenberg, Johanna M W Hazes, Tom Huizinga, Meghna Jani, Dmitry Karateev, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain McInnes, Eduardo Mysler, Peter Nash, Karel Pavelka, Gyula Poór, Christophe Richez, Piet van Riel, Andrea Rubbert-Roth, Kenneth Saag, Jose da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde

Open source

DOI: 10.1136/annrheumdis-2016-210715
Published: 2017-06
Container: Annals of the Rheumatic Diseases
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/annrheumdis-2016-210715,
  title = {EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update},
  author = {Josef S Smolen and Robert Landewé and Johannes Bijlsma and Gerd Burmester and Katerina Chatzidionysiou and Maxime Dougados and Jackie Nam and Sofia Ramiro and Marieke Voshaar and Ronald van Vollenhoven and Daniel Aletaha and Martin Aringer and Maarten Boers and Chris D Buckley and Frank Buttgereit and Vivian Bykerk and Mario Cardiel and Bernard Combe and Maurizio Cutolo and Yvonne van Eijk-Hustings and Paul Emery and Axel Finckh and Cem Gabay and Juan Gomez-Reino and Laure Gossec and Jacques-Eric Gottenberg and Johanna M W Hazes and Tom Huizinga and Meghna Jani and Dmitry Karateev and Marios Kouloumas and Tore Kvien and Zhanguo Li and Xavier Mariette and Iain McInnes and Eduardo Mysler and Peter Nash and Karel Pavelka and Gyula Poór and Christophe Richez and Piet van Riel and Andrea Rubbert-Roth and Kenneth Saag and Jose da Silva and Tanja Stamm and Tsutomu Takeuchi and René Westhovens and Maarten de Wit and Désirée van der Heijde},
  year = {2017},
  journal = {Annals of the Rheumatic Diseases},
  doi = {10.1136/annrheumdis-2016-210715},
  url = {https://doi.org/10.1136/annrheumdis-2016-210715}
}

RIS

TY  - JOUR
TI  - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
AU  - Josef S Smolen
AU  - Robert Landewé
AU  - Johannes Bijlsma
AU  - Gerd Burmester
AU  - Katerina Chatzidionysiou
AU  - Maxime Dougados
AU  - Jackie Nam
AU  - Sofia Ramiro
AU  - Marieke Voshaar
AU  - Ronald van Vollenhoven
AU  - Daniel Aletaha
AU  - Martin Aringer
AU  - Maarten Boers
AU  - Chris D Buckley
AU  - Frank Buttgereit
AU  - Vivian Bykerk
AU  - Mario Cardiel
AU  - Bernard Combe
AU  - Maurizio Cutolo
AU  - Yvonne van Eijk-Hustings
AU  - Paul Emery
AU  - Axel Finckh
AU  - Cem Gabay
AU  - Juan Gomez-Reino
AU  - Laure Gossec
AU  - Jacques-Eric Gottenberg
AU  - Johanna M W Hazes
AU  - Tom Huizinga
AU  - Meghna Jani
AU  - Dmitry Karateev
AU  - Marios Kouloumas
AU  - Tore Kvien
AU  - Zhanguo Li
AU  - Xavier Mariette
AU  - Iain McInnes
AU  - Eduardo Mysler
AU  - Peter Nash
AU  - Karel Pavelka
AU  - Gyula Poór
AU  - Christophe Richez
AU  - Piet van Riel
AU  - Andrea Rubbert-Roth
AU  - Kenneth Saag
AU  - Jose da Silva
AU  - Tanja Stamm
AU  - Tsutomu Takeuchi
AU  - René Westhovens
AU  - Maarten de Wit
AU  - Désirée van der Heijde
PY  - 2017
JO  - Annals of the Rheumatic Diseases
DO  - 10.1136/annrheumdis-2016-210715
UR  - https://doi.org/10.1136/annrheumdis-2016-210715
ER  -

APA

Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., Vollenhoven, R. V., Aletaha, D., Aringer, M., Boers, M., Buckley, C. D., Buttgereit, F., Bykerk, V., Cardiel, M., Combe, B., Cutolo, M., Eijk-Hustings, Y. V., Emery, P., Finckh, A., Gabay, C., Gomez-Reino, J., Gossec, L., Gottenberg, J., Hazes, J. M. W., Huizinga, T., Jani, M., Karateev, D., Kouloumas, M., Kvien, T., Li, Z., Mariette, X., McInnes, I., Mysler, E., Nash, P., Pavelka, K., Poór, G., Richez, C., Riel, P. V., Rubbert-Roth, A., Saag, K., Silva, J. D., Stamm, T., Takeuchi, T., Westhovens, R., Wit, M. D., & Heijde, D. V. D. (2017). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2016-210715

Source records

crossref · retrieved 2026-09-26T11:49:58.520Z